Detalles de la búsqueda
1.
BRCA1 and MDM2 as independent blood-based biomarkers of head and neck cancer.
Tumour Biol
; 2016 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27714671
2.
XPD, APE1, and MUTYH polymorphisms increase head and neck cancer risk: effect of gene-gene and gene-environment interactions.
Tumour Biol
; 36(10): 7569-79, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25916209
3.
Low level of BRCA2 in peripheral blood lymphocytes is associated with an increased risk for head and neck squamous cell carcinoma (HNSCC) in a population of North-East India: a case-control study.
Ecancermedicalscience
; 17: 1503, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37113717
4.
The GSTM1 and GSTT1 Null Genotypes Increase the Risk for Type 2 Diabetes Mellitus and the Subsequent Development of Diabetic Complications: A Meta-analysis.
Curr Diabetes Rev
; 15(1): 31-43, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-29243583
5.
Association between OGG1 Ser326Cys polymorphism and risk of upper aero-digestive tract and gastrointestinal cancers: a meta-analysis.
Springerplus
; 5: 227, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27026921
6.
ATM rs189037 (G > A) polymorphism and risk of lung cancer and head and neck cancer: A meta-analysis.
Meta Gene
; 6: 42-8, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26504743
7.
MDM2 and TP53 Polymorphisms as Predictive Markers for Head and Neck Cancer in Northeast Indian Population: Effect of Gene-Gene and Gene-Environment Interactions.
Asian Pac J Cancer Prev
; 16(14): 5767-72, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26320449
Resultados
1 -
7
de 7
1
Próxima >
>>